Michael Merz - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Michael Merz

Showing results (71-80 of 73) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 73 results.

Plos One|December 30, 2017

Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recoveryValentina Peta, Chantal Tse, Hugo Perazzo, et al.

Drug Discovery Today|May 17, 2011

A generic operational strategy to qualify translational safety biomarkersKatja Matheis, David Laurie, Christiane Andriamandroso, et al.

Hepatology (Baltimore, Md.)|January 23, 2018

Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effortRachel J Church, Gerd A Kullak-Ublick, Jiri Aubrecht, et al.

Pageof 8

Search research articles

Showing results (71-80 of 73) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 73 results.

Plos One|December 30, 2017

Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recoveryValentina Peta, Chantal Tse, Hugo Perazzo, et al.

Drug Discovery Today|May 17, 2011

A generic operational strategy to qualify translational safety biomarkersKatja Matheis, David Laurie, Christiane Andriamandroso, et al.

Hepatology (Baltimore, Md.)|January 23, 2018

Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effortRachel J Church, Gerd A Kullak-Ublick, Jiri Aubrecht, et al.

Pageof 8